Loss of methylation in CpG sites in the NF-?B enhancer elements of inducible nitric oxide synthase is responsible for gene induction in human articular chondrocytes

OBJECTIVE.: To investigate whether the abnormal expression of inducible nitric oxide synthase (iNOS) by osteoarthritic (OA) human chondrocytes is associated with changes in the DNA methylation status in the promoter and/or enhancer elements of iNOS. METHODS.: Expression of iNOS was quantified by qRT...

Full description

Bibliographic Details
Main Authors: de Andrés, María C. (Author), Imagawa, Kei (Author), Hashimoto, Ko (Author), Gonzalez, Antonio (Author), Roach, Helmtrud I. (Author), Goldring, Mary B. (Author), Oreffo, Richard O.C (Author)
Format: Article
Language:English
Published: 2013-03.
Subjects:
Online Access:Get fulltext
LEADER 02696 am a22001933u 4500
001 346416
042 |a dc 
100 1 0 |a de Andrés, María C.  |e author 
700 1 0 |a Imagawa, Kei  |e author 
700 1 0 |a Hashimoto, Ko  |e author 
700 1 0 |a Gonzalez, Antonio  |e author 
700 1 0 |a Roach, Helmtrud I.  |e author 
700 1 0 |a Goldring, Mary B.  |e author 
700 1 0 |a Oreffo, Richard O.C.  |e author 
245 0 0 |a Loss of methylation in CpG sites in the NF-?B enhancer elements of inducible nitric oxide synthase is responsible for gene induction in human articular chondrocytes 
260 |c 2013-03. 
856 |z Get fulltext  |u https://eprints.soton.ac.uk/346416/1/Loss%2520of%2520methylation%2520in%2520CpG%2520sites%2520in%2520the%2520NF-%25CE%25BAB%2520enhancer%2520elements%2520of%2520inducible%2520nitric%2520oxide%2520synthase%2520is%2520responsible%2520for%2520gene%2520induction%2520in%2520human%2520articular%2520chondrocytes.pdf 
520 |a OBJECTIVE.: To investigate whether the abnormal expression of inducible nitric oxide synthase (iNOS) by osteoarthritic (OA) human chondrocytes is associated with changes in the DNA methylation status in the promoter and/or enhancer elements of iNOS. METHODS.: Expression of iNOS was quantified by qRT-PCR. The DNA methylation status of the iNOS promoter and enhancer regions was determined by bisulfite sequencing or pyrosequencing. The effect of CpG methylation on iNOS promoter and enhancer activities was determined using a CpG-free luciferase vector and a CpG methyltransferase. Co-transfections with expression vectors encoding NF-?B subunits were carried out to analyse iNOS promoter and enhancer activities in response to changes in methylation status. RESULTS.: The 1000-bp iNOS promoter has only 7 CpG sites, 6 of which were highly methylated in both controls and OA samples; the CpG site at -289 and the sites in the starting coding region were largely un-methylated in both groups. The NF-?B enhancer region at -5.8 kb was significantly de-methylated in OA samples compared with control samples. This enhancer element was transactivated by co-transfection with the NF-?B subunits p65 alone or together with p50. Critically, methylation treatment of the iNOS enhancer element significantly decreased its activity in reporter assay. CONCLUSIONS.: These studies demonstrate the association between de-methylation of specific NF-?B-responsive enhancer elements and the activation of iNOS transactivation in human OA chondrocytes, consistent with the differences in methylation status observed in vivo in normal and human OA cartilage and, critically, show association with the osteoarthritic process. © 2012 American College of Rheumatology. 
655 7 |a Article